NCT04048733

Brief Summary

In this study, the investigators compare timely acquirement of 12-lead ECG using patchy-type wireless versus using standard 12-lead ECG system among patient with chest pain in ED. The purpose of this study is to determine the difference of timely acquirement of 12-lead ECG using two different systems and the difference of hospital delay in ED between two groups. The participants were randomly divided into 2 groups: one performing an ECG examination using the standard 12-lead ECG and the other using the patch-type mobile 12-lead ECG.The 12-lead ECG will be taken 2 times serially in every 15 minutes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 31, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 7, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2019

Completed
Last Updated

October 23, 2020

Status Verified

October 1, 2020

Enrollment Period

2 months

First QC Date

July 31, 2019

Last Update Submit

October 21, 2020

Conditions

Keywords

ElectrocardiographyChest painEmergency Service,HospitalWireless Technology

Outcome Measures

Primary Outcomes (2)

  • Time from ordering to performing 12-lead ECGs during up to 24 hours in ED.

    Comparison of interval from the anticipated time to take 12-lead ECG to the time actually performed will be measured.

    measure the time duration from ECG ordering to performing during up to 24 hours in ED

  • Time from ordering to verifying 12-lead ECGs by ED physician during up to 24 hours in ED.

    Comparison of interval from the anticipated time to take 12-lead ECG to the time verified by physician

    measure the time duration from ECG ordering to verifying by ED physician during up to 24 hours in ED

Secondary Outcomes (1)

  • The Presence of artifacts in 12-lead ECGs.

    ECG reading and checking of presence of artifacts in 12 lead ECGs through study completion, an average of 1 month.

Study Arms (2)

Patchy type-lead ECG

EXPERIMENTAL

ED physicians will prescribe to perform second and third 12-lead ECG in every 15 minutes. Second and third 12 lead ECG will be taken using patchy-type 12-lead ECG device as a doctor's order. This device will be automatically record 12-lead ECG 3 times in 1 minutes at a time by its algorithm.

Device: patchy-type wireless 12-lead ECG

Standard 12-lead ECG

NO INTERVENTION

ED physicians will prescribe to perform second and third 12-lead ECG in every 15 minutes. Second and third 12 lead ECG will be taken using standard 12-lead ECG device as a doctor's order. Interns and ECG technicians will perform 12-lead ECG as they perform as usual.

Interventions

Perform 12-lead ECG using patchy-type wireless 12-lead ECG. This device automatically record 12-lead ECG in every 15 minutes by its algorithm.

Patchy type-lead ECG

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A subject who visited the ER with a cardiogenic chest pain
  • adult patients over 19 years of age
  • A subject who completed the 1st ECG

You may not qualify if:

  • A subject who did not agree with this study
  • arrest patient
  • Dead on arrival
  • STEMI patients who confirmed by 1st ECG in ER
  • shock status patient in triage state

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, Gangnam, 06351, South Korea

Location

MeSH Terms

Conditions

Chest PainEmergencies

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Officials

  • wonchul cha, doctoral

    samsumg medical center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2019

First Posted

August 7, 2019

Study Start

July 30, 2019

Primary Completion

October 8, 2019

Study Completion

December 16, 2019

Last Updated

October 23, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations